Study Stopped
Use of Formocresol for pulpotomies ws discontinued.
Electrical and Formocresol Pulpotomy in Primary Molars
A Prospective Study and Clinical Evaluation of Pre & Post Operative Treatment Comparison of Electrical and Formocresol Pulpotomy Procedures in Primary Molars of Children Undergoing General Anesthesia
1 other identifier
interventional
120
1 country
1
Brief Summary
- 1.The investigator hypothesize that the Laser pulpotomy will provide adequate and comparable success clinically in primary molars.
- 2.The investigators hypothesize that the Laser pulpotomy will provide adequate and comparable success radiographically in primary molars.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 14, 2012
CompletedFirst Posted
Study publicly available on registry
June 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedMay 10, 2017
May 1, 2017
3 years
June 14, 2012
May 9, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Radiographic
Failure is identified as radiographic: furcation radiolucency, external root resorption
6, 12, and 18 months
Secondary Outcomes (1)
Clinical
6, 12, 18 months
Study Arms (2)
Formocresol (control)
PLACEBO COMPARATORThis will consist of patients who are ASA I or II status, 3-8 years old, males and females, and present with restorable primary molars with reversible pulpitis and free of clinical radiographic signs of pulp pathology. From these study participants, they will be randomly assigned to this or other group. Patients in this group will receive a pulpotomy. Cotton pellets are saturated with conventional 1:5 dilution of Buckley's formocresol into the canal orifice for 5 minutes for complete hemostasis. IRM (Zinc Oxide Eugenol) cement will then be placed to seal the pulp chamber. A stainless steel crown will be cemented with Ketac Cement that was triturated for 10 seconds to complete the pulpotomy procedure and final restoration.
Laser
ACTIVE COMPARATORThis will consist of patients who are ASA I or II status, 3-8 years old, males and females, and present with restorable primary molars with reversible pulpitis and free of clinical radiographic signs of pulp pathology. From these study participants, they will be randomly assigned to this or other group. Patients in this group will receive a pulpotomy. Then a GENTLEray 980 Soft Tissue diode laser (Power: 3.0W, Mode: PW, Fiber: 300µm, Ton: 100ms, Toff: 100ms, Timer: cont) will be used to vaporize the residual pulp tissue and complete hemostasis. IRM (Zinc Oxide Eugenol) cement is then placed to seal the pulp chamber. A stainless steel crown cemented with Ketac Cement for the full coverage final restoration completes the pulpotomy procedure.
Interventions
1:5 Buckley's Formocresol dilution applied for 5 minutes or until hemostasis achieved
Application to pulp chamber until hemostasis achieved
Eligibility Criteria
You may qualify if:
- Restorable carious primary molars with reversible pulpitis and free of clinical or radiographic signs of pulp pathology
- Males and females
- Children ages 3-8 years old
- Children classified under ASA I or II status
You may not qualify if:
- Excluded will be primary molars with clinical or radiographic signs of pathology
- Children not within age range
- Absence of parent/caregiver
- Mentally disabled parent/caregiver
- Patients not returning for 6 month and 12 month follow up examination appointment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital-Rainbow Babies & Children's Hospital
Cleveland, Ohio, 44106, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gerald A Ferretti, DDS, MS, MPH
University Hospitals Cleveland Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair of Pediatric Dentistry
Study Record Dates
First Submitted
June 14, 2012
First Posted
June 18, 2012
Study Start
June 1, 2011
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
May 10, 2017
Record last verified: 2017-05